1-4 of 4
Thorsten Marquardt
Close
Sort by
Journal Articles

Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter

Clinical Trials & Observations
Yvonne Helmus, Jonas Denecke, Sviatlana Yakubenia, Peter Robinson, Kerstin Lühn, Diana L. Watson, Paraic J. McGrogan, Dietmar Vestweber, Thorsten Marquardt, Martin K. Wild
Journal: Blood
Blood (2006) 107 (10): 3959–3966.
https://doi.org/10.1182/blood-2005-08-3334
Published: 2006
Includes: Supplemental data
Journal Articles

Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation

Clinical Trials & Observations
Hermann Heimpel, Volker Anselstetter, Ladislav Chrobak, Jonas Denecke, Beate Einsiedler, Kerstin Gallmeier, Antje Griesshammer, Thorsten Marquardt, Gritta Janka-Schaub, Martina Kron, Elisabeth Kohne
Journal: Blood
Blood (2003) 102 (13): 4576–4581.
https://doi.org/10.1182/blood-2003-02-0613
Published: 2003
Journal Articles

Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts

Clinical Trials & Observations Brief Report
Kerstin Lühn, Thorsten Marquardt, Erik Harms, Dietmar Vestweber
Journal: Blood
Blood (2001) 97 (1): 330–332.
https://doi.org/10.1182/blood.V97.1.330
Published: 2001
Journal Articles

Correction of Leukocyte Adhesion Deficiency Type II With Oral Fucose

Thorsten Marquardt, Kerstin Lühn, Geetha Srikrishna, Hudson H. Freeze, Erik Harms, Dietmar Vestweber
Journal: Blood
Blood (1999) 94 (12): 3976–3985.
https://doi.org/10.1182/blood.V94.12.3976
Published: 1999